Please provide your email address to receive an email when new articles are posted on . Clobetasol propionate ophthalmic suspension 0.05% for postoperative inflammation and pain after ocular surgery ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Clobetasol propionate ophthalmic suspension 0.05% was ...

Both coprimary endpoints were statistically significantly better in Clobetasol Propionate Ophthalmic Suspension 0.05%-treated patients compared with vehicle-treated patients. The Food and Drug ...

(RTTNews) - Eyenovia, Inc. (EYEN) on Tuesday revealed that Taiwan-based Formosa Pharmaceuticals' clobetasol propionate ophthalmic suspension eye drops has received FDA's approval. This approval marks ...

TAIPEI, March 4, 2024 /PRNewswire/ -- Taiwan-based Formosa Pharmaceuticals (6838.TWO) and AimMax Therapeutics (United States) announced today that the U.S. Food and Drug Administration (FDA) has ...

(RTTNews) - Taro Pharmaceuticals U.S.A., Inc. has recalled one lot of corticosteroid Clobetasol Propionate in the form of ointment for the potential presence of Ralstonia pickettii bacteria, the U.S.

TAIPEI, Aug. 7, 2024 /PRNewswire/ -- Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TWO) announced today that the company has signed a non-binding terms agreement with Eyenovia, Inc. ("Eyenovia ...

Taiwan-based Formosa Pharmaceuticals has entered into an exclusive licensing agreement with Apotex for exclusive rights in Mexico for the commercialization of clobetasol propionate ophthalmic ...